Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Denali Therapeutics	Fate Therapeutics	Regenxbio	Cortexyme	Editas Medicine
Symbol	NASDAQ:DNLI	NASDAQ:FATE	NASDAQ:RGNX	NASDAQ:CRTX	NASDAQ:EDIT
Price Information
Current Price	$26.20	$29.61	$54.01	$58.97	$26.54
52 Week Range	Buy	Buy	Buy	Hold	Buy
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Hold	Buy
Consensus Price Target	$29.57	$26.63	$77.50	$34.25	$42.00
% Upside from Price Target	12.87% upside	-10.08% downside	43.49% upside	-41.92% downside	58.25% upside
Trade Information
Market Cap	$2.53 billion	$2.18 billion	$1.96 billion	$1.95 billion	$1.38 billion
Beta	2.05	1.95	0.83	N/A	2.65
Average Volume	794,766	880,942	432,541	172,152	707,875
Sales & Book Value
Annual Revenue	$129.16 million	$4.74 million	$218.51 million	N/A	$31.94 million
Price / Sales	19.48	472.22	9.10	N/A	42.63
Cashflow	N/A	N/A	$2.58 per share	N/A	N/A
Price / Cash	N/A	N/A	20.95	N/A	N/A
Book Value	$5.76 per share	$2.48 per share	$14.20 per share	N/A	$4.94 per share
Price / Book	4.55	11.94	3.80	N/A	5.37
Profitability
Net Income	$-36,240,000.00	$-66,600,000.00	$99.94 million	$-12,480,000.00	$-109,950,000.00
EPS	($0.39)	($1.19)	$2.38	N/A	($2.33)
Trailing P/E Ratio	N/A	N/A	N/A	0.00	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-44.73%	-900.24%	-99.57%	N/A	-842.47%
Return on Equity (ROE)	-13.37%	-48.94%	-18.74%	-58.22%	-56.53%
Return on Assets (ROA)	-10.24%	-35.27%	-17.47%	-26.73%	-31.70%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.16%	0.10%	0.01%	N/A	0.06%
Current Ratio	10.59%	7.53%	11.49%	20.30%	5.08%
Quick Ratio	10.59%	7.53%	11.49%	20.30%	5.08%
Ownership Information
Institutional Ownership Percentage	72.98%	96.95%	78.05%	21.53%	84.74%
Insider Ownership Percentage	21.20%	23.19%	13.80%	N/A	0.94%
Miscellaneous
Employees	179	104	192	16	133
Shares Outstanding	96.03 million	75.59 million	36.81 million	26.85 million	51.30 million
Next Earnings Date	3/10/2020 (Estimated)	3/3/2020 (Estimated)	2/26/2020 (Estimated)	2/25/2020 (Estimated)	2/27/2020 (Estimated)
Optionable	Optionable	Optionable	Optionable	Not Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources